Abstract
The aim of this study was to investigate the opinions of healthy students regarding the acceptability of placebo treatment if they were to experience depression. A survey was conducted among 344 students in five academic centers in Israel. After a thorough explanation of the placebo effect, its efficacy and limitations in the treatment of depression, the study participants completed a 32-item self-report questionnaire. Seventy percent (n = 243) of the participants answered that they would agree to treatment with a placebo as a first-line treatment if they were to experience depression in the future. Eighty-eight percent (n = 297) of the subjects did not think that a physician who administered placebos was deceitful. Once aware of the possible benefits and limitations of placebo treatment, most of our study population was willing to accept placebo as a legitimate treatment of depression. Additional studies on the possible use of placebo as an effective, safe, and acceptable form of therapy are warranted.
| Original language | English |
|---|---|
| Pages (from-to) | 345-347 |
| Number of pages | 3 |
| Journal | Journal of Nervous and Mental Disease |
| Volume | 201 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 2013 |
Keywords
- Placebo
- depression
- informed consent
- treatment
Fingerprint
Dive into the research topics of 'Consenting not to be informed: A survey on the acceptability of placebo use in the treatment of depression'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver